To investigate the potential role of mtDNA alterations during the onset of colorectal cancer, the occurrence of mtDNA variants in colorectal adenomatous (Tubular, Tubulovillous, and Villous) polyps, were studied. High resolution endonucleases and PCR-based sequence were applied to examine mtDNA variants in the ND and ATPase genes of 64 primary tissues of colorectal adenopolyps and their matched normal controls. Forty-two variants were observed and 57% (24/42) were not previously reported in the MITODAT reference. Fifty-eight percent of these variants were germline and homoplasmic transitions. The distribution of observed mtDNA variants includes: 31% (13/42) tubular, 52% (22/42) tubulovillous, 45% (19/42) villous, and 45% (19/42) cancer (including FAP and JVP). Notably, an unreported germline variant in the ATPase 8 gene at nucleotide position (np) G8573A was observed in tubulovillous adenomas tissues. The results suggest that some specific mtDNA variants may serve as a potential biomarker for colorectal adenomatous polyps.
ABSTRACT
To investigate the potential role of mtDNA alterations during the onset of colorectal cancer, the occurrence of mtDNA variants in colorectal adenomatous (Tubular, Tubulovillous, and Villous) polyps, were studied. High resolution endonucleases and PCR-based sequence were applied to examine mtDNA variants in the ND and ATPase genes of 64 primary tissues of colorectal adenopolyps and their matched normal controls. Forty-two variants were observed and 57% (24/42) were not previously reported in the MITODAT reference. Fifty-eight percent of these variants were germline and homoplasmic transitions. The distribution of observed mtDNA variants includes: 31% (13/42) tubular, 52% (22/42) tubulovillous, 45% (19/42) villous, and 45% (19/42) cancer (including FAP and JVP). Notably, an unreported germline variant in the ATPase 8 gene at nucleotide position (np) G8573A was observed in tubulovillous adenomas tissues. The results suggest that some specific mtDNA variants may serve as a potential biomarker for colorectal adenomatous polyps.
INTRODUCTION
Mitochondria are necessary intracellular organelles that, as the nucleus, posses a separate genome and all the enzymatic machinery translating genetic information into proteins (1-3). Human mitochondrial gene mutations are increasingly being associated with unclear pathophysiological significances for various cancers (4) (5) (6) (7) (8) (9) . MtDNA is a circular molecule of 16.6 kb containing 37 genes including 2 ribosomal RNAs, 22tRNAs, required for translation of mtDNA, and 13 polypeptides that encode subunits of the respiratory chain (10) . Mitochondria are mainly responsible for the production of energy in the form of ATP and are an important source of excited oxygen species (11) . Mitochondria have been implicated in cancer given their role in oxidative phosphorylation of Reactive Oxygen Species (ROS) and apoptosis (6) . Apoptosis serves an essential role in cellular response to anticancer agents and development of cancer. Mitochondria contribution to tumorigenesis is necessary to understand the biology of cancer development. Past studies indicated that Characterization of 33 patients and 64 collected samples of these patients mtDNA content can regulate cancer progression, and accumulation in mtDNA mutations have been associated with the impairment of mitochondrial function which is involved in the etiology of aging and several degenerative pathologies (12) (13) (14) (15) . Additionally, studies have suggested that mitochondrial function decreases with aging and is associated with the process of tumorigenesis (16; 17; 18) . Moreover, mtDNA abnormalities in the hypervariable regions and mtDNA-encoded Complexes I, III-IV, have been found in cancer tissues (8) .
Given that colorectal cancer (CRC) is an age related disease, we examined the correlation of mtDNA variants with early colorectal adenopolyps. In this communication we report the finding of a high incidence of mtDNA alterations in the ATPase 8 gene in the tissues of tubulovillous of colorectal adeno-polyps. Based on a relative distribution of mtDNA mutations observed in this study, a 2.2kb of mtDNA encompassing the ND and ATPase 8 regions may be useful in providing a framework for further differentiation studies of colorectal adenopolyps tissues.
MATERIALS AND METHODS

Subjects
We collected sixty-four frozen colorectal adenomatous polyp tissues including their precancerous normal surrounding tissues (NST) of the three polyps and cancer (Tubular: 9 Tumor, 9 NST; Tubulovillous: 10 
High resolution restriction endonucleases and PCRbased analysis of mtDNA variants
To increase the quality of target DNA extracted from small samples, laser-capture micro-dissection was performed on the selected tissue samples with the use of an Arctus PixCell II microscope (Arcturus Engineering) for replication of the distance between the polyps and matched surrounding precancerous normal-appearing cells. . PCR fragments were directly sequenced with same PCR primers to identify the exact nature of new length variants detected by restriction analysis and assess presence of any other mtDNA mutations that exist among and within samples. Sequences of both sense and anti-sense strands were derived with ABI 3130xl Gene Analyzer.
Analysis of the mtDNA Sequences
Sequence alignments were performed using ABI Sequence Scanner Version 1.0. The results of the mtDNA sequence analysis were compared with MITOMAP database to verify if the changes detected had previously been reported (Table 2) . Sequence variants present in both tumor and NST were scored as germ-line variants. Any mtDNA sequence variant that was different between the tumor and the NST were scored as somatic mtDNA mutations. Sequence variants within a tissue type of tumor or normal were define as heteroplasmy. 
RESULTS AND DISCUSSION
Two regions of mtDNA were analyzed from 64 samples of colorectal adenomatous polyps and their matched surrounding precancerous normal tissues ( Table 2 ). The observed cumulative frequency of mtDNA variants in tubular and tubulovillous samples is consistent with our previous studies except the observed variants were lower in cancer samples, which could be an indication of the small cancer samples size used in this study (6) . Eighteen of the 42 (43%) mutations were not previously reported based on the MITOMAP reference (http://www.mitomap.org). Variant C11867G was unreported and found in ~60% of the selected samples of villous adenopolyps and NST. Notably, a heteroplasmic variants C11868T/A was found in tubulovillous adenopolyps (~70%), also in villous (14%) and cancer samples (38%), but not tubular adenopolyps. (19) (20) (21) (22) (23) (24) (25) (26) (27) . In the ND5 region, we observed a somatic variant of A12553C, and a germline variant at np C12554A in our reference samples, cancer subtype tissues, n=3 (not JVP or FAP). Diseases, such as mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes; Leber Hereditary optic neuropathy; Leigh syndrome and, Mitochondrial complex I deficiency have also been associated with mtDNA variants in this region (7; 28-33) . Furthermore, the ATPase 8 and the ND5 of the NADH subunits, are essential for protein synthesis of the mitochondria, any dysfunctions in these genes affect the oxidative phosphorylation (OXPHOS). Therefore, determination of the functionality of these observed variants in association with transformation of colorectal adenopolyps in a large population will be interesting.
In conclusion, this study demonstrates a high frequency of mtDNA variants in colorectal tubulovillous and villous adenopolyp tissue samples possessed more morphology of colorectal carcinoma based on the observed level of frequency of 45% (19/42) mtDNA variants in villous and cancer tissues used in this study. Given that villous carcinoma are associated with the highest morbidity and mortality rates than of all polyps, it could be harboring carcinoma in situ or invasive carcinoma more frequently than the other adenomas (7). Whether these observed mtDNA variants are directly associated with the development and progression of colorectal cancer, is still unclear and was not the purpose of our current study but it will be an interesting area that warrants further investigation.
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